Dr. Jorge Mera, Director of Infectious Diseases for the Cherokee Nation Health Service, provides a general overview of HCV elimination and micro-elimination, as well as an overview of the Cherokee… […]
Audience: Clinical
Neurobiology and Diagnosis of SUDs | January 17, 2019
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, reviews the diagnostic criteria for substance use disorders and examines the different ways in which substance use… […]
Read More… from Neurobiology and Diagnosis of SUDs | January 17, 2019
The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018
Annette Hewitt and Lisa Townshend-Bulson, Family Nurse Practitioners from the Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program, present on the impact of sustained virologic response (SVR) on… […]
Read More… from The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018
Opioid Substitution Therapy and the HCV-Provider | November 28, 2018
Dr. Aaron Skiles, a Family Nurse Practitioner with the UNM Sandoval Regional Medical Center, shares knowledge on the opioid epidemic, the merits of opioid substitution therapy, and the role of… […]
Read More… from Opioid Substitution Therapy and the HCV-Provider | November 28, 2018
HCV in Pregnant Women: How the Opioid Crisis is Changing the Landscape | September 26, 2018
Dr. Francheska Sevy Gurule, a Maternal Child Health Fellow at the University of New Mexico, Department of Family and Community Medicine, presents on the impact the opioid crisis has had… […]
Interdisciplinary Care at Shoshone-Bannock | September 13, 2018
A brief overview of healthcare services offered at the Shoshone-Bannock Fort Hall IHS facility and the Shoshone-Bannock Department of Tribal Health and Human Services, as well as the design and… […]
Read More… from Interdisciplinary Care at Shoshone-Bannock | September 13, 2018
Long Term Follow-Up After HCV Treatment | September 11, 2018
Dr. Paulina Deming, an Associate Professor of Pharmacy at the University of New Mexico Sciences Center, discusses the needed follow-up for patients with and without cirrhosis who have completed HCV… […]
Read More… from Long Term Follow-Up After HCV Treatment | September 11, 2018
Addressing Transient Elastography (FibroScan): Integrating with HCV Care | Addressing Starting an HCV Clinic at Crow/Northern Cheyenne | August 25, 2018
Dr. Justin Iwasaki, the Executive Medical Director at Lummi Tribal Health Center (LTHC), discusses the creation and design considerations of the HCV Elimination Program at the LTHC, and then he… […]
Addressing Transient Elastography (FibroScan): Integrating with HCV Care | August 14, 2018
Dr. Youssef Barbour, a Liver Specialist at the Alaska Native Medical Center, provides an overview of transient elastography (FibroScan) and the role that it can play in treating liver disease. […]
Diabetic Retinopathy and Neuropathy: 2018 Clinical Practice Guidelines | August 9, 2018
In this presentation, Dr. Richard Arakaki, professor at the University of Hawaii John A. Burns School of Medicine, shares information about 2018 clinical practice guidelines for diabetic retinopathy and neuropathy. […]
